Home
Journal Information
About
Aims and Scope
Editorial Board
Editor in Chief
Open Access
Editorial Office
Editorial Policies
Journal Issues
Current Issue
In Press
All Issues
Contact Us
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
2008-5117
eISSN
:
2008-6830
Submit Your Paper
Instructions for Authors
Instructions for Reviewers
Editor in Chief
Editorial Board
Editorial Policies
English Editing Service
Indexing and Abstracting
Archive
Platinum Open Access
This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.
Indexing Info
Collaborator of
J Cardiovasc Thorac Res
. 2022;14(2): 77-83. doi:
10.34172/jcvtr.2022.14
PMID:
35935390
PMCID:
PMC9339732
Review Article
A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases
Neda Roshanravan
1
, Helda Tutunchi
2
, Farzad Najafipour
2
, Mohammadreza Dastouri
3
*
, Samad Ghaffari
1
*
, Alireza Jebeli
1
Cited by CrossRef: 1
1- Alradwan I, AL Fayez N, Alomary M, Alshehri A, Aodah A, Almughem F, Alsulami K, Aldossary A, Alawad A, Tawfik Y, Tawfik E. Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging.
Pharmaceutics
. 2024;16(8):1037
[Crossref]
2- Wal P, Aziz N, Singh C, Rasheed A, Tyagi L, Agrawal A, Wal A. Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders.
CGT
. 2024;24(5):356
[Crossref]
3- Moore O, Ho K, Copeland J, Parthasarathy V, Wehrens X. Genome Editing and Cardiac Arrhythmias.
Cells
. 2023;12(10):1363
[Crossref]